HomeAI · summaries
Storia in 2 fonti
Zydus Lifesciences gets USFDA nod for generic ascorbic acid injection
Zydus Lifesciences secured final USFDA approval for its generic ascorbic acid injection. This approval is for the treatment of scurvy in specific patient groups. The company's product is the generic equivalent of the Ascor injection. The USFDA designated this application as a Competitive Generic Therapy. Zydus will market the product in the United States market.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Zydus Lifesciences gets USFDA nod for generic ascorbic acid injection
Zydus Lifesciences secured final USFDA approval for its generic ascorbic acid injection. This approval is for the treatment of scurvy in specific patient groups. The company's…
- ·
thehindu.com
Zydus secures U.S. FDA nod for scurvy injection generic
Zydus Lifesciences gains U.S. FDA approval for generic Ascorbic Acid Injection, used for treating scurvy, enhancing market competition.